Header Logo

Connection

ABDUL AZIZ SIDDIQUI to Adult

Back to Details
This is a "connection" page, showing publications ABDUL AZIZ SIDDIQUI has written about Adult.
ABDUL AZIZ SIDDIQUI
Connection Strength
0.014
Adult
  1. Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trial. Nat Med. 2025 Oct; 31(10):3504-3513.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.